{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immune response",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:119245",
      "entity_text" : "dioscin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We reasoned that dioscin treatment could attenuate the devastating Th1 immune response, leading to a relatively milder Th2 response; however, future studies are needed for confirmation.",
  "reading_complete" : "2020-08-03T13:32:46Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:30:37Z",
  "trigger" : "attenuate",
  "evidence" : [ "dioscin treatment could attenuate the devastating Th1 immune response" ],
  "pmc_id" : "5695011",
  "score" : 0
}